April 15, 2024Gynecological EndocrinologyOpen Access

Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients

View Full Paper

Ask AI

Bookmark

Abstract

Objective To evaluate the effects of alpha lipoic acid (ALA) on hormonal and metabolic parameters in a group of overweight/obese Polycystic Ovary Syndrome (PCOS) patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Genazzani et al. (2024) studied this question.

synapsesocial.com/papers/68e6f047b6db64358766ae81 https://doi.org/10.1080/09513590.2024.2341701

View Full Paper

Ask AI

Bookmark

Abstract

Objective To evaluate the effects of alpha lipoic acid (ALA) on hormonal and metabolic parameters in a group of overweight/obese Polycystic Ovary Syndrome (PCOS) patients.

Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients

Abstract

Discussion

Cite This Study

Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients

Abstract

Discussion

Cite This Study

Keep reading

Keep reading